Sarah Milsom

Chief Operating Officer

Professional Overview
Sarah Milsom is a seasoned healthcare executive with extensive experience in strategic and operational leadership. As the Chief Operating Officer at EyeBio, she is responsible for driving the company's day-to-day operations, optimizing processes, and ensuring the efficient delivery of innovative ophthalmology solutions.

Experience Summary

Current Role
As the Chief Operating Officer at EyeBio, Sarah is responsible for overseeing the company's operations, including production, supply chain, and quality control. She has been instrumental in streamlining workflows, improving operational efficiency, and aligning the organization's activities with its strategic objectives. Under her leadership, EyeBio has experienced a significant increase in productivity and customer satisfaction.

Career Progression
Prior to her current role, Sarah served as the Vice President of Translation at Touchlight Genetics Ltd., where she led the company's efforts to translate research into viable commercial products. In this position, she demonstrated her ability to navigate complex regulatory landscapes and effectively manage cross-functional teams. Earlier in her career, Sarah worked as a Strategy Consultant at L.E.K. Consulting, where she provided strategic insights and optimization solutions to clients in the healthcare and life sciences sectors.

Academic Background
Sarah holds a Master's degree in Business Administration from the University of Cambridge, where she specialized in strategic management and innovation. She has also completed executive leadership programs at Harvard Business School, further enhancing her expertise in driving organizational transformation and delivering sustainable growth.

Areas of Expertise

• Healthcare operations management

• Strategic planning and implementation

• Process optimization and productivity improvement

• Cross-functional team leadership and collaboration

• Regulatory compliance and market access

Professional Impact
During her tenure at Touchlight Genetics Ltd., Sarah spearheaded the successful launch of two new ophthalmology products, contributing to a 25% increase in the company's market share. As a Strategy Consultant at L.E.K. Consulting, she led multiple client engagements that resulted in significant cost savings and revenue growth for her clients.

Conclusion
With her comprehensive experience in healthcare operations, strategic leadership, and a proven track record of driving organizational transformation, Sarah Milsom is well-positioned to continue her successful career as the Chief Operating Officer at EyeBio. Her deep industry expertise and commitment to excellence make her a valuable asset in the ever-evolving ophthalmology landscape.